Featured Research

from universities, journals, and other organizations

Visceral Leishmaniasis: Successful Vaccine Trial In Dogs

Date:
August 16, 2005
Source:
Institut de Recherche Pour le Développement
Summary:
Visceral leishmaniasis, which is the most severe form of that group of diseases, affects 500,000 people in the world each year. In the most heavily affected areas, the dog population is hit heavily by infection. It acts as parasite reservoir for humans. A prevention treatment has just been tested successfully on dogs by an IRD team in Montpellier, in conjunction with the Rocher veterinary clinic (La Garde, Var) and the biopharmaceutical company Bio Véto Test (La Seyne-Sur-Mer, Var).

Visceral leishmaniasis, which is the most severe form ofthat group of diseases, affects 500 000 people in the world each year.It is caused by a protozoan, Leishmania infantum, transmitted by sandfly bites. There is no vaccine for this disease, which can rapidly leadto death if no treatment is given. In the most heavily affected areas,the dog population is hit heavily by infection. It acts as parasitereservoir for humans. Development of a vaccine for dogs could helpbrake transmission of the disease to humans, by reducing thisreservoir. Such prevention treatment has just been tested successfullyon dogs by an IRD team in Montpellier, in conjunction with the Rocherveterinary clinic (La Garde, Var) and the biopharmaceutical company BioVéto Test (La Seyne-Sur-Mer, Var). The first results showed totallasting protection of these animals against the disease, could open theway towards the development of a human vaccine.

Related Articles


Visceralleishmaniasis, which is the most severe form of the leishmaniases, hitsan annual total of 500 000 people, mostly in the developing countries.It is caused by the parasite Leishmania infantum. A flagellateprotozoan, it uses as vector an insect resembling a midge, the sandfly, colonizing the intestine and then the salivary glands. The femaleinsect feeds on mammals’ blood. It can thus pass the parasite on tohumans by a single bite. Once in the blood stream, L. infantum passesinto particular cells of the immune system, the macrophages. Theseeventually burst, releasing the parasites which move on to penetrateother cells. The infected subject suffers bouts of fever, anaemia,enlarged spleen and liver, and weight loss. In the absence oftreatment, these clinical signs usually announce a fatal outcome.

Thesand fly sucks blood from mammals other than humans. This is how, rightaround the Mediterranean rim, 5 million dogs, a proportion of from 1 to42 % depending on the area, are affected by visceral leishmaniasis.These animals are thus a reservoir for these parasites, whichcontinuously feed the mammal-sand fly-human cycle. In this context,development of a canine vaccine would help reduce the portion of theanimal population infected. The risks of transmission of the disease tohumans would in this way be indirectly reduced.

Up to now,several dog vaccines, mostly developed from whole dried parasites, haveproved not to be really effective. A team from the IRD Montpellierresearch centre, working with the Rocher veterinary clinic (La Garde,Var, France) and the biopharmaceutical firm Bio Véto Test (LaSeyne-Sur-Mer, Var), have recently produced and tested a new type oftreatment, composed solely of antigen proteins excreted by the parasite(1). The first trials indicate that this would completely and lastinglyprotect dogs against the disease.

Twelve out of 18 dogs includedin the study were treated with increasing doses of protein antigensexcreted by the parasite (that is 50, 100, 200 micrograms) made up to aformula with an adjuvant. The other six received no treatment. Twoinjections at an interval of three weeks resulted in infection of allthe animals with L. infantum. They were followed up for two years inorder to monitor the progress of the disease. The mixture of parasiteproteins proved to be especially effective, as 100% protection wasobtained for the doses of 100 micrograms (six immunized dogs out ofsix) and 200 micrograms (three out of three).

The researchersalso focused on the changes to the immune system brought on by thevaccination. Laboratory experiments showed that the effectiveness ofthe vaccine stems from the activation of certain cells of the immunesystem, the T lymphocytes of type Th1. These induce the infectedmacrophages to produce nitric oxide, highly toxic for cells. Thisprocess, which did not occur in the untreated dogs, thus enablesmacrophages to get rid of the parasites that are infecting them. Theanimal thus acquires long-term protection against visceralleishmaniasis.

Although this vaccine’s effectiveness has beenshown only on a limited number of animals, it is a further step towardsprotection of dogs against this disease. These results, confirmedindeed by the first, highly encouraging, data from a large-scaleclinical trial currently under way (phase III), are promising forefforts to reduce transmission of leishmaniasis to humans. They alsopoint to new lines of investigation for elaborating a possible humanvaccine. An integrated research project, involving several IRD groups(2), has just been set up in India, to work on this. It should lead toan assessment of the effectiveness of such a vaccine in humans.

(1) The finding of these proteins furthermore necessitated thedevelopment, achieved in 1992, of suitable culture media (patented),with the attached proteins removed. The media normally used ijn factcontain many protein-containing compounds (serumalbumins, albuminsetc.) which prevent specific isolation of the proteins excreted by theparasite. References : Lemesre J.L., Blanc M.P., Grébaut P., ZilberfardV. et Carrière V. (1994). Culture continue de formes amastigotes deLeishmanies en condition axénique. Réalisation du cycle évolutif invitro. Médecine et Armées, 22 (1), 99 and Merlen T, Sereno D, Brajon N.and Lemesre J.L. (1999). Leishmania Spp: completely defined mediumwithout serum and macromolecules (CDM/LP) for the continuous in vitrocultivation of infective promastigote forms. Am. J. Trop. Med. Hyg., 60(1), 41-50. Brevets : Lemesre J.L. (1993). "Procédé de culture in vitrode différents stades parasitaires obtenus et applications biologiques".Brevet français, FR n° 93 05779 ; Lemesre J.L. (1994)."Method for theculture in vitro of different stages of tissue parasites".Brevetinternational, PCT/FR N° 94/00577.

(2) The project, entitled «Study of the host and parasite factors determining the outcome ofvisceral leishmaniasis: application for prevention and treatment »,involves research IRD units UR 08 « Trypanosome pathogenesis » and 165« Genetics and evolution of infectious diseases », in conjunction withthe Institute of Medical Sciences, Banares Hindu University, Varanasi,India.


Story Source:

The above story is based on materials provided by Institut de Recherche Pour le Développement. Note: Materials may be edited for content and length.


Cite This Page:

Institut de Recherche Pour le Développement. "Visceral Leishmaniasis: Successful Vaccine Trial In Dogs." ScienceDaily. ScienceDaily, 16 August 2005. <www.sciencedaily.com/releases/2005/08/050814165616.htm>.
Institut de Recherche Pour le Développement. (2005, August 16). Visceral Leishmaniasis: Successful Vaccine Trial In Dogs. ScienceDaily. Retrieved January 27, 2015 from www.sciencedaily.com/releases/2005/08/050814165616.htm
Institut de Recherche Pour le Développement. "Visceral Leishmaniasis: Successful Vaccine Trial In Dogs." ScienceDaily. www.sciencedaily.com/releases/2005/08/050814165616.htm (accessed January 27, 2015).

Share This


More From ScienceDaily



More Plants & Animals News

Tuesday, January 27, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How To: Mixed Green Salad Topped With Camembert Cheese

How To: Mixed Green Salad Topped With Camembert Cheese

Rumble (Jan. 26, 2015) — Learn how to make a mixed green salad topped with a pan-seared camembert cheese in only a minute! Music: Courtesy of Audio Network. Video provided by Rumble
Powered by NewsLook.com
Water Fleas Prepare for Space Voyage

Water Fleas Prepare for Space Voyage

Reuters - Innovations Video Online (Jan. 26, 2015) — Scientists are preparing a group of water fleas for a unique voyage into space. The aquatic crustaceans, known as Daphnia, can be used as a miniature model for biomedical research, and their reproductive and swimming behaviour will be tested for signs of stress while on board the International Space Station. Jim Drury went to meet the team. Video provided by Reuters
Powered by NewsLook.com
Husky Puppy Plays With Ferret

Husky Puppy Plays With Ferret

Rumble (Jan. 26, 2015) — It looks like this 2-month-old Husky puppy and the family ferret are going to be the best of friends. Look at how much fun they&apos;re having together! Credit to &apos;Vira&apos;. Video provided by Rumble
Powered by NewsLook.com
Scientists Model Flying, Walking Drone After Vampire Bats

Scientists Model Flying, Walking Drone After Vampire Bats

Buzz60 (Jan. 26, 2015) — Swiss scientists build a new drone that can both fly and walk, modeling it after the movements of common vampire bats. Jen Markham (@jenmarkham) has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins